Atlas FDA

TransPyloric Shuttle/TransPyloric Shuttle Delivery Device

FDA premarket approval P180024 · decided 2019-04-16

Approval details

PMA number
P180024
Trade name
TransPyloric Shuttle/TransPyloric Shuttle Delivery Device
Generic name
IMPLANT, INTRAGASTRIC FOR MORBID OBESITY
Applicant
Baronova, Inc.
Date received
2018-07-09
Decision date
2019-04-16
Days to decision
281 days
Decision code
APPR
Product code
LTI
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
San Carlos, CA
Statement
Approval for the TransPyloric Shuttle/TransPyloric Shuttle Delivery Device. The TransPyloric Shuttle/TransPyloric Shuttle Delivery Device is indicated for weight reduction in adult patients with obesity with a Body Mass Index (BMI) of 35.0-40.0 kg/m2 or a BMI of 30.0 to 34.9 kg/m2 with one or more obesity-related comorbid conditions and is intended to be used in conjunction with a diet and behavior modification program.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
BAROnova Access Sheath Kit (K191078)Baronova, Inc.2019-07-22
BAROnova Insufflation System, BAROnova Accessory Kit (K190985)Baronova, Inc.2019-05-14
BAROnova Retrieval Kit, BAROnova Overtube, BAROnova Endoscope Cap (K172575)Baronova, Inc.2018-01-18